| Elite Chiropractic & Tissue Rehabilitation, Llc | |
|
8 W 56th St Suite A1 East Kearney NE 68847-0505 | |
| (308) 455-1500 | |
| (308) 455-1502 |
| Full Name | Elite Chiropractic & Tissue Rehabilitation, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 8 W 56th St, Kearney, Nebraska |
| Authorized Official Name and Position | Cory J Stickney (MANAGER) |
| Authorized Official Contact | 3084551500 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Elite Chiropractic & Tissue Rehabilitation, Llc 8 W 56th St Suite A1 East Kearney NE 68847-0505 Ph: (308) 455-1500 | Elite Chiropractic & Tissue Rehabilitation, Llc 8 W 56th St Suite A1 East Kearney NE 68847-0505 Ph: (308) 455-1500 |
| NPI Number | 1295036630 |
|---|---|
| Provider Enumeration Date | 11/16/2010 |
| Last Update Date | 01/28/2016 |
| Medicare PECOS PAC ID | 2961682794 |
|---|---|
| Medicare Enrollment ID | O20110210000461 |
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295036630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 39 (Nebraska) | Primary |
| Provider Name | Cory Joseph Stickney |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1295035814 PECOS PAC ID: 3870773609 Enrollment ID: I20110210000505 |
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
| Provider Name | Matthew Barth |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1235484593 PECOS PAC ID: 7719137090 Enrollment ID: I20121022000803 |
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
| Provider Name | Trevor John Peterson |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1801133186 PECOS PAC ID: 3678728318 Enrollment ID: I20130301000142 |
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
| Provider Name | Jessica L Pratt |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1447504568 PECOS PAC ID: 9739308883 Enrollment ID: I20140922002679 |
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
| Provider Name | Collin T Sears |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1215525464 PECOS PAC ID: 8022422062 Enrollment ID: I20210202002376 |
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
| Provider Name | Isaac Skylar Stansbury |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1053198663 PECOS PAC ID: 5092162693 Enrollment ID: I20231102003745 |
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
News Archive
The next "next-gen" technology in genome sequencing has gotten a major boost.
No doubt proteins are complex. Most are "large" and full of interdependent branches, pockets and bends in their final folded structure.
Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou's intellectual property.
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
High family stress can lead to the child's immune system being affected, as a research group at the School of Health Sciences at Jönköping University and the Faculty of Health Sciences at Linköping University in Sweden shows in a study being published in the renowned American periodical Journal of Immunology.
› Verified 2 days ago
Board Of Regents, University Of Nebraska Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2510 11th Avenue, Msab Rm 184, Kearney, NE 68849 Phone: 308-865-8964 Fax: 308-865-8218 | |
Dr. Amy Lange, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 417 E 35th St, Kearney, NE 68847 Phone: 312-508-9610 | |
Platte Valley Medical Group, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2263 Fax: 308-865-2541 | |
Tim Mason Family Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5205 2nd Ave, Kearney, NE 68847 Phone: 308-440-2983 | |
Tiffany L Byrkit Pac Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 803 17th Ave, Kearney, NE 68845 Phone: 308-440-7807 | |
Platte Valley Medical Clinic, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 816 22nd Ave Suite 100, Kearney, NE 68845 Phone: 308-865-2263 Fax: 308-865-2541 |